At a glance
- Originator Millennium Pharmaceuticals
- Class Analgesics
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 26 Jan 2000 LeukoSite has been merged into Millennium Pharmaceuticals
- 24 Feb 1999 CytoMed has been wholly acquired by LeukoSite
- 26 Nov 1997 New profile